KAMAZ Publicly Traded Company (KMAZ)
Moscow Exchange · Russia · prices in RUB · close of 22 Oct 2026
Key indicators
| Last close | RUB 57.20 |
|---|---|
| 52-week range | 39.40 – 94.00 |
| Return, 1 month / 3 months | +0.9% / +18.4% |
| Return, 1 year / 3 years | −31.3% / −76.4% |
| Trend | Below its 200-day average |
| RSI (14) | 56 |
| Volatility (1 year) | 35.2% |
| Worst drawdown (1 year) | -57.0% |
| Average daily value traded | 35.55M RUB |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
KAMAZ Publicly Traded Company is a Russian vehicle manufacturer based in Naberezhnye Chelny. It builds heavy-duty trucks for freight haulage, construction and mining work, along with buses, diesel engines and related components. Its customers include transport operators, industrial firms and public fleets, and its vehicles are also supplied for military use. The company runs its own production plants and a service network across Russia and exports to several overseas markets.
KAMAZ Publicly Traded Company trades under the code KMAZ on the Moscow Exchange in Russia, with its price quoted in Russian rubles (RUB). Our dividend records, which start in 2019, show payments in 3 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
KAMAZ Publicly Traded Company (KMAZ) trades on the Moscow Exchange in Russia. It last closed at RUB 57.20 on 22 October 2026.
Its price-based Market X-Ray is 42 out of 100 (a weak price profile), ranking 167 of 250 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 31.3% and over the last three months it rose 18.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Moscow Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 30 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -12.6% | ||
| From 52-week high | -38.8% | ||
| Momentum | 43 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | 18.4% | ||
| 6-month return | -22.4% | ||
| 12-month return, skipping the last month | -31.9% | ||
| Stability (higher is calmer) | 40 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 35.2% | ||
| Worst drawdown, 1 year (smaller is calmer) | -57.0% | ||
| Liquidity | 65 · Fair | Moderate trading activity. | |
| Average daily value traded | 35.55M RUB | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 2 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
Returns
| 1 week | −0.9% |
|---|---|
| 1 month | +0.9% |
| 3 months | +18.4% |
| 6 months | −22.4% |
| 1 year | −31.3% |
| 3 years | −76.4% |
| 5 years | −51.8% |
Signals
| 50-day / 200-day average | 54.71 / 65.42 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.63 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Jul 2024 | RUB 1.8000 |
| 10 Jul 2023 | RUB 1.8400 |
| 16 Jun 2023 | RUB 0.7210 |
| 16 Jun 2021 | RUB 0.5400 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Moscow Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.